Accelerated Solutions for Your Regulatory Review
Aquila Solutions was founded in 2010 with the primary purpose of aiding small to medium pharmaceutical and biologic companies with navigating the regulatory systems. We have successfully published applications for biologics, sterile products, and combination products, among others.
The services that Aquila offers include most forms of eCTD Regulatory Publishing, Regulatory Consulting and Strategy, and Project Management as well as Label Authoring. We pride ourselves on our accuracy, flexibility, and fast turnaround.
In addition to our Publishing and Project Management services, Aquila Solutions is proud to offer editorial revision and minor formatting, as well as technical assessment and verification of existing applications.
Our Top Accomplishments
Approximate pharma submissions done annually
submissions can be done same day / next day
submissions marked as Refuse to File
News & Events
The FDA has provided clarity on developing new orphan drugs for the Age of Individualized Medicine.
Happy New Year! Is a new IND or other drug product in your New Year’s Resolution? Contact us!
eCTD viewer “Altair” has entered beta testing! Contact us for more information.
Aquila to attend and present at DIA 2021